Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure

Nikola Kozhuharov1,2, Eleni Michou1, Desiree Wussler1

  • 1Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland.

Biomedicines
|May 25, 2024
PubMed

Insights

Normotensive acute heart failure (AHF) patients exhibit greater cardiac stress and cardiomyocyte injury than hypertensive AHF patients. This biomarker difference in AHF is linked to increased mortality risk.

Area of Science:

  • Cardiology
  • Acute Heart Failure Pathophysiology
  • Biomarker Analysis

Background:

  • Understanding pathophysiological differences between normotensive and hypertensive acute heart failure (AHF) is crucial for personalized treatment strategies.
  • Acute heart failure presents unique challenges in diagnosis and management based on blood pressure levels.

Purpose of the Study:

  • To compare the extent of hemodynamic cardiac stress and cardiomyocyte injury in normotensive versus hypertensive AHF.
  • To investigate the association between these pathophysiological markers and all-cause mortality in AHF patients.

Main Methods:

  • Conducted a study on 1152 AHF patients, classifying them as normotensive (SBP 90-140 mmHg) or hypertensive (SBP > 140 mmHg).
  • Quantified hemodynamic stress using B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels.
  • Assessed cardiomyocyte injury via high-sensitivity cardiac troponin T (hs-cTnT) measurements.
  • Validated findings in an independent cohort of 324 AHF patients.

Main Results:

  • Normotensive AHF patients showed significantly higher BNP, NT-proBNP, and hs-cTnT levels compared to hypertensive AHF patients (p < 0.001 for all).
  • All-cause mortality within 360 days was significantly higher in normotensive AHF patients (HR 1.66, p < 0.001).
  • Elevated BNP, NT-proBNP, or hs-cTnT in normotensive AHF patients correlated with the highest mortality rates.

Conclusions:

  • Biomarker profiling indicates greater hemodynamic stress and cardiomyocyte injury in normotensive AHF compared to hypertensive AHF.
  • These findings highlight distinct pathophysiological profiles and prognostic implications for normotensive and hypertensive AHF.
Abstract